pre-clinical data for novel egfr inhibitor bdtx-1535
Published 2 years ago • 124 plays • Length 3:29Download video MP4
Download video MP3
Similar videos
-
3:14
bdtx-1535: a novel treatment for egfr-mutated nsclc and glioblastoma
-
4:54
unmet needs in glioblastoma that egfr inhibitor bdtx-1535 aims to address
-
4:04
unmet needs in nsclc that egfr inhibitor bdtx-1535 aims to address
-
3:31
cell death and differentiation: a novel treatment of cystic fibrosis acting on-target
-
1:07
egfr mutation for lung cancer | egfr inhibitors | diagnosis & symptoms of egfr-positive lung cancer
-
2:05
assess trial: blood test for egfr mutation in advanced non-small cell lung cancer
-
1:00
7 things to know about immunotherapy
-
2:55
audio described: clinical trial tests nivolumab for patients with rare brain and spine cancers
-
1:33
investigating egfr resistance mutations in routine genomic profiling
-
2:00
clinical trial tests nivolumab for patients with rare brain and spine cancers
-
0:50
research into new immunotherapies for breast cancer
-
5:50
a phase ib single-arm study of bintrafusp alfa
-
3:40
precision cancer medicine: jeff's story | dana-farber/brigham and women's cancer center
-
3:01
egfr – precision medicine: identifying and attacking genetic flaws | dana-farber cancer institute
-
1:13
outcomes following fd & nfd related donor haplo transplantation for patients with acute leukemias
-
2:55
ebmt research grant
-
2:15
jin-a02: a highly effective 4th generation egfr-tki, targeting egfr c797s triple mutation in nsclc
-
2:32
improving the efficacy of mapoe-targeted liposomes by mmp2-controlled drug release in gbm